Babraham BioMed

BioMed Realty has completed the lease-up of its Babraham Research Campus in Cambridgeshire – showcasing the strength of the life science sector in the UK.

The Oxford Cambridge Arc is set to be the focus of numerous developments of this type over the coming year, and despite the Covid-19 this announcement is a major boost for the regional economy.

Bit Bio, a world-leader in synthetic biology, is set to take 25,000 sq ft of space at the site which now means the whole 100,000 sq ft of mixed laboratory and office space has been leased within the first year.

BioMed Realty – owned by Blackstone, the leading global investment firm – entered the UK marketplace in 2012 and have dedicated themselves to developing first class Grade A lab space and office space for the life sciences sector, and therefore the East of England with its unique reputation for innovation has been a key area for the firm. They’re set to speak on our Developing Science and Innovation Parks Conference later this year to reveal their next plans and projects.

Matt Smith, Director of the UK Market at BioMed Realty, said: “The life sciences industry makes a huge contribution to the UK economy, supporting thousands of highly skilled jobs. With the right investment in facilities to help nurture innovation, it will provide the industry a path for growth and compete globally with knowledge clusters across the US, Europe and Asia. We’ve seen unprecedented demand for high quality research space and full credit must be given to Derek Jones and the Babraham Research Campus for being one of the first organisations in Britain to recognise the huge value of offering turnkey facilities to spin-outs and scale-ups.”